Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. C. Donnelly, M. E. Armstrong, A. Joshi, G. Cooke, I. Kemal, R. Ananda-Kumar, L. Li, J. Baugh, D. Shields, D. R. Moller, C. M. Hogaboam (Dublin, Ireland; Ann Arbor, Baltimore, United States Of America). LSC 2010 Abstract: Defective toll-like receptor-3 (TLR3) function promotes persistent interstitial lung disease and fibrosis in sarcoidosis. Eur Respir J 2010; 36: Suppl. 54, 3430

Member's Comments

No comment yet.

Related content which might interest you: LSC Abstract – Toll-like receptor 4 (TLR4) in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – IPF pathogenesis Year: 2015 Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1 Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 Altered expression of toll-like receptor (TLR)-2 and TLR-4 on alveolar macrophages (AM) in inflammatory lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 588s Year: 2003 A possible role for toll-like receptor (TLR) 5 in fibrotic pulmonary sarcoidosis Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21 Source: Eur Respir J 2007; 29: 1082-1093 Year: 2007 Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 LSC 2010 Abstract: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 CXCR1 and CXCR2 haplotypes synergistically modulate cystic fibrosis lung disease Source: Eur Respir J 2012; 39: 1385-1390 Year: 2012 Increased expression of toll-like receptor 2 (TLR2) in the small airways of fatal asthma Source: Eur Respir J 2007; 30: Suppl. 51, 285s Year: 2007 Elevated integrin ?5 expression in idiopathic pulmonary fibrosis (IPF) derived fibroblasts is linked to paracrine TNF-a signaling Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017 MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF alveolar macrophages Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Source: Eur Respir J 2008; 32: 1068-1081 Year: 2008 LSC 2010 Abstract: Dysregulated inflammatory and apoptotic responses to human rhinovirus in primary airway cells from young patients with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections Year: 2010 CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 701-707 Year: 2005 Influence of Toll-like receptor 4 (TLR4) on cellular signaling of acute lung injury Source: Eur Respir J 2003; 22: Suppl. 45, 268s Year: 2003 PAR-2 agonists induce TGF-beta and EMT leading to lung fibrosis Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease Source: Eur Respir J 2007; 30: 736-742 Year: 2007